Company Profile
Updated: 09-DEC-09Brain Food Inc.
Private Company, Headquarters Location
4004 E Side Ave., Dallas, TX 75226, United States
(214)720-0700,
Primary SIC: Computer Related Services, Not Elsewhere Classified, Primary NAICS: Computer Systems Design Services
Description: Services: Computer Related Services Data Processing/Preparation
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
New Neurostimulation Patient Programming Software Enables More Thorough and Efficient Capture of Complex Pain Patterns.
Biotech Week; 12/16/2009; 785 words; St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration...St. Jude Medical, Inc.). MultiSteering...pain signals to the brain. "This latest software...St. Jude Medical Inc. This article was prepared...
St. Jude Medical Receives FDA Approval for Industry-First Five-Column Neurostimulation Lead to Manage Chronic Pain.
Biotech Week; 12/16/2009; 802 words; St. Jude Medical, Inc. (NYSE:STJ) announced the U.S. Food and Drug Administration...also St. Jude Medical, Inc.). This innovative...of pain signals to the brain. Electrodes on the lead...Administration, St. Jude Medical Inc. This article was prepared...
Research in the area of applied microbiology reported from Agricultural University.(Report)
Life Science Weekly; 12/15/2009; 841 words; ...from spoiled meat were transferred to Brain Heart Infusion broth inoculated with 103...Laboratory Microbiology & Biotechnology Foods, Dept. of Food Science & Technology, Iera Odos 75...Microbiology is: Wiley-Blackwell Publishing, Inc., Commerce Place, 350 Main St., Malden...
Hyperion Therapeutics Enrolls First Patient in Phase II Hepatic Encephalopathy Trial.(Clinical report)
Clinical Trials Week; 12/14/2009; 1616 words; ...Hyperion Therapeutics, Inc. announced that the first...believed to occur when the brain is exposed to gut-derived...teaspoons of powder mixed with food or dissolved in liquid...Hyperion and Ucyclyd Pharma, Inc., a subsidiary of Medicis...Hyperion Therapeutics, Inc.). BUPHENYL is a ...
AstraZeneca and Targacept Form Global Collaboration and License Agreement for Late-stage Investigational Product TC-5214 for the Treatment of Major Depressive Disorder.
Clinical Trials Week; 12/14/2009; 1582 words; AstraZeneca and Targacept, Inc. announced a collaboration and...subtypes (see also Targacept, Inc.). Major Depressive Disorder...application (NDA) with the US Food and Drug Administration (FDA...NNRs and other receptors in the brain that are activated by the neurotransmitter...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning